APOE epsilon 4 favours vascular over parenchymal deposition of A beta protein in Alzheimer's disease by Chalmers, K, Wilcock, G, Love, S

Neurofibrillary tangles interfere with transduction of TGF-beta signalling by neurons by Chalmers, K, Wilcock, G, Love, S

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. by Chalmers, K, Wilcock, G, Love, S

Contributors to white matter damage in Alzheimer's disease by Chalmers, K, Wilcock, G, Love, S

Contributors to white matter damage in the frontal lobe in Alzheimer's disease. by Chalmers, K, Wilcock, G, Love, S

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. by Williams, S, Chalmers, K, Wilcock, G, Love, S

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease by Williams, S, Chalmers, K, Wilcock, G, Love, S

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease by Chalmers, K, Zhang, Y, Love, S, Wilcock, G, Kehoe, P

Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies by Chalmers, K, Wilcock, G, Vinters, H, Perry, E, Ballard, C, Love, S

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. by Chalmers, K, Culpan, D, Kehoe, P, Wilcock, G, Hughes, A, Love, S

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. by Miners, J, Van Helmond, Z, Chalmers, K, Wilcock, G, Love, S, Kehoe, P

Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy by Miners, J, van Helmond, Z, Chalmers, K, Wilcock, G, Love, S, Kehoe, P

A new kind of spatial inattention associated with chronic limb pain? by Reid, E, Wallwork, S, Harvie, D, Chalmers, K, Gallace, A, Spence, C, Moseley, G

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. by Chalmers, K, Wilcock, G, Vinters, H, Perry, E, Perry, R, Ballard, C, Love, S

Spatially-defined motor deficits in people with unilateral complex regional pain syndrome by Reid, E, Braithwaite, F, Wallwork, S, Harvie, D, Chalmers, K, Spence, C, Gallace, A, Moseley, G

Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease. by van Helmond, Z, Miners, J, Bednall, E, Chalmers, K, Zhang, Y, Wilcock, G, Love, S, Kehoe, P

Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. by Ballard, C, Chalmers, K, Todd, C, McKeith, I, O'Brien, J, Wilcock, G, Love, S, Perry, E

Key methodological issues for the design and delivery of placebo controlled randomised trials of invasive procedures, including surgery: A systematic review by Cousins, S, Tsang, C, Blencowe, N, Lorenc, A, Chalmers, K, Carr, A, Campbell, M, Cook, J, Beard, D, Blazeby, J

Optimising the design and delivery of placebo surgical interventions in randomised controlled trials: The DITTO framework by Cousins, S, Tsang, C, Blencowe, N, Chalmers, K, Mardanpour, A, Carr, A, Campbell, M, Cook, J, Beard, D, Blazeby, J

Optimizing the design of invasive placebo interventions in randomized controlled trials by Cousins, S, Blencowe, NS, Tsang, C, Chalmers, K, Mardanpour, A, Carr, AJ, Campbell, MK, Cook, JA, Beard, DJ, Blazeby, JM